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Commentary
about 135 have been already accepted for publication. 
Most of them are focused on the more appropriate 
surgical treatment for this condition. Indeed, despite its 
high incidence, no consensus has been reached on the 
most effective surgical technique, even after randomized 
controlled trials and wide meta‑analyses.[3,4] Considering 
that the selection of the most appropriate surgical 
management is a prominent key of success, the relevance 
of this discussion is evident.[4] In their paper,  Martin 
et al. report their technique, consisting in the insertion 
of two drainages through a burr hole, to achieve a 
better irrigation of the hematoma and a reduction of 
the risk of postoperative pneumocephalus.[5] The paper 
is interesting because, as stated by the authors, they 
combine some known technical principles of CSDH 
surgery, such as postoperative drainage, saline solution 
irrigation, with some innovative nuances to reduce 
the presence of postoperative intracranial air, which is 
known to be associated to a higher risk of recurrence of 
the hematoma.[5]
Although we strongly believe that the efforts by the 
authors are commendable, we, also, consider that it is 
time to change the paradigm in the scientific literature on 
this field.[6] Indeed, for some aspects, the final prognosis 
Although the incidence of chronic subdural hematoma 
(CSDH) is assessed about 1–5.3 case per 100,000 
individuals yearly, this is a real emerging disease in 
consideration to the increasing average age of the 
general population.[1] For such reasons, this disease 
may have a deep effect on the socio‑sanitary systems 
of many countries, leading to a progressive increase of 
healthcare costs and patient hospitalization.[1] Moreover, 
CSDH has a relevant impact, also, for patients: indeed, 
in fragile elderly ones, often with multiple comorbidities, 
the reduction of autonomous activities in daily life 
may lead to a relevant decrease of their quality of life, 
and according to some studies, also, to a reduction in 
the expected survival time.[2] Furthermore, it has been 
suggested to consider CSDH as a form of reversible 
dementia, with a progressive decline in mental and 
physical performance, sometimes associated to clear 
focal neurological deficits, which can be reversed after 
treatment, at least to some degrees.[1]
Based on these considerations, it is not surprising that 
this condition is central in the scientifical debate, as 
demonstrated by a large number of publications in the 
field. In 2017, 191 papers were reported in the medical 
literature on this topic, and in the first 9 months of 2018, 
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of patients with CSDH is only partially dependent on the 
technical issue, it is, also, due to the patient’s clinical 
condition, comorbidities, and medical therapies.[7,8] 
To some extent, we face the paradoxical scenario that 
one of the less technical demanding neurosurgical 
maneuver, usually quick, with low complication, and 
even not always requiring general anesthesia, could 
lead to scarcely acceptable results. Indeed, if we accept 
that CSDH manifests as a reversible form of dementia, 
the aim of any treatment should be the restoring of 
the patients’ previous quality of life, independence in 
daily activities, and general performance. However, 
a common observation in routine practice is that the 
functional sequelae are often severe, also in cases with 
an excellent surgical outcome of the hematoma. In 
fact, in a not negligible rate of cases, the final clinical 
status is far from the desirable, with a substantial 
regression of quality of life.[6‑8] We agree with many 
studies that the comorbidities of patients, their initial 
clinical conditions, and the radiological features of the 
hematoma are relevant prognostic factors, which should 
be considered to predict the final patient’s outcome.[6‑8] 
Revising our surgical experience on 216 CSDH cases 
operated between 2013 and 2015, we found that patients 
older than 81 (hazard ratio [HR]: 6.16 e P < 0.0001), 
with cardiological comorbidities (HR: 1.88 e P = 0.04.), 
or chronic pneumatics (HR: 2.43, P = 0.003), or 
preoperative dementia (HR: 2.04, P = 0.03) or worse 
neurological condition at surgery, evaluated basing on the 
Glasgow Coma Scale (HR: 2.04, P = 0.03), presented a 
shorter survival time at a multivariate statistical analysis 
despite the resolution of CSDH on postoperative scans.
Considering the prominent costs of CSDH not only for 
the health systems but also for patients, caregivers, their 
families, and for the society, we consider that the main 
issue in this pathology is the discrepancy between the 
easy and quick technical aspects of this surgery and the 
poor prognosis of some of these cases. Therefore, we 
hope that future studies will enlighten the role of each of 
prognostic factor, to help clinicians in the more difficult 
issue in CSDH: the selection of the better surgical 
indications as possible.
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